Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension

References

• Chobanian AV, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension42, 1206–1252 (2003).
   PubMed Web of Science ®Google Scholar
• Mancia G, DeBecker G, Dominiczak A et al. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens.25, 1105–1187 (2007).
   PubMed Web of Science ®Google Scholar
• Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness; treatment, and control of hypertension among United States adults 1999–2004. Hypertension49, 69–75 (2007).
   PubMed Web of Science ®Google Scholar
• Materson BJ, Reda DJ, Cushman WC et al.; The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. N. Engl. J. Med.328, 914–921 (1993).
   PubMed Web of Science ®Google Scholar
• Chrysant SG, Melino M, Karki S, Lee J, Heyrman R. The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8 week factorial efficacy and safety study. Clin. Ther.30, 587–604 (2008).
   PubMed Web of Science ®Google Scholar
• Philipp T, Smith TR, Glazer R et al. Two multicenter, 8-week, randomized, double-blind, placebo controlled, parallel group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Clin. Ther.29, 563–580 (2007).
   PubMed Web of Science ®Google Scholar
• Destro M, Lukow A, Samson A, Kandra A, Brunel P. Efficacy and safety of amlodipine/valsartan compared with amlodipine monotherapy in patients with stage 2 hypertension: a randomized double-blind, multicenter study EX-EFFECTS study. J. Am. Soc. Hypertens.2, 294–302 (2008).
   PubMed Web of Science ®Google Scholar
• Littlejohn TW, Mazul CR, Olvera R et al. Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized placebo-controlled parallel group, 4 × 4 factorial study. Postgrad. Med.121, 5–14 (2009).
   PubMed Web of Science ®Google Scholar
• Ausubel H, Levine ML. Treatment of hypertension with Ser-Ap-Es. Curr. Ther. Clin. Exp.9, 29–35 (1967).
   PubMed Web of Science ®Google Scholar
• Chrysant SG. Using fixed-dose combination therapies to achieve blood pressure goals. Clin. Drug Invest.28, 713–734 (2008).
   PubMed Web of Science ®Google Scholar
• Gradman AH, Cutler NR, Davis PJ, Robbins JA, Weis RJ, Wood BC. Combined enalapril and felodipine extended release (ER) for systemic hypertension. Enalapril–Felodipine–ER Factorial Study Group. Am. J. Cardiol.79, 431–435 (1997).
   PubMed Web of Science ®Google Scholar
• Chrysant SG, Bakris GL. Amlodipine/benazepril monotherapy. Am. J. Hypertens.17, 590–596 (2004).
   PubMed Web of Science ®Google Scholar
• Chrysant SG, Gavras H, Niederman AI, Marbury TC, Goldstein R. Clinical utility of long-term enalapril/diltaizem ER in stage 3–4 essential hypertension. J. Clin. Pharmacol.37, 810–815 (1997).
   PubMed Web of Science ®Google Scholar
• DeQuattro V, Lee D, Messerli FH; The Trandolapril Study Group. Fixed-dose combination therapy with trandolapril and verapamil SR in primary hypertension. A 4 × 4 trail design. Clin. Exp. Hypertens.19, 373–387 (1999).
   Web of Science ®Google Scholar
• Chrysant SG, Sugimoto DH, Lefkowitz M et al. The effects of high-dose amlodipine/benazepril combination therapies on blood pressure reduction in patients not adequately controlled with amlodipine monotherapy. Blood Press.16(Suppl. 1), 10–17 (2007).
   Web of Science ®Google Scholar
• Moser M. From JNC1 to JNC7. What have we learned? Prog. Cardiovasc. Dis.48, 303–315 (2006).
   PubMed Web of Science ®Google Scholar
• Fagan TC. Remembering the lessons of basic pharmacology. Arch. Intern. Med.154, 1430–1431 (1994).
   PubMed Web of Science ®Google Scholar
• Chrysant SG. Fixed low-dose drug combination for the treatment of hypertension. Arch. Fam. Med.7, 370–376 (1998).
   PubMedGoogle Scholar
• Sica DA. Fixed-dose combination of antihypertensive drugs. Do they have a role in rational therapy? Drugs48, 16–24 (1994).
   PubMed Web of Science ®Google Scholar
• Epstein M, Bakris G. Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy. Arch. Intern. Med.156, 1969–1978 (1996).
   PubMed Web of Science ®Google Scholar
• Messerli FH. Combination therapy in hypertension. J. Hum. Hypertens.6(Suppl. 2), S19–S21 (1992).
   PubMed Web of Science ®Google Scholar
• Chrysant SG, Cohen M. Sustained blood pressure control with controlled-release isradipine (isradipine CR). J. Clin. Pharmacol.35, 239–243 (1995).
   PubMed Web of Science ®Google Scholar
• Chrysant SG, Marbury TC, Robinson TD. Antihypertensive efficacy and safety of olmesartan medoxomil compared to amlodipine for mild-to-moderate hypertension. J. Hum. Hypertens.17, 425–432 (2003).
   PubMed Web of Science ®Google Scholar
• Chrysant SG. Proactive compared with passive event recognition: calcium channel blocker associated edema. J. Clin. Hypertens.10, 16–22 (2008).
   Google Scholar
• Cappuccio FP, Markandu ND, Sagnella GA et al. Effects of amlodipine on urinary sodium excretion, renin-angiotensin-aldosterone system, atrial natriuretic peptide and blood pressure in essential hypertension. J. Hum. Hypertens.5, 115–119 (1996).
   Google Scholar
• Chrysant SG. Using fixed-dose combination therapies to achieve blood pressure control. Clin. Drug Invest.28, 713–734 (2008).
   PubMed Web of Science ®Google Scholar
• Bagalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am. J. Med.120, 713–719 (2007).
   PubMed Web of Science ®Google Scholar
• Lewington S, Clarke R, Orizilbash N et al.; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data from one million adults in 61 prospective studies. Lancet360, 1903–1913 (2002).
   PubMed Web of Science ®Google Scholar
• Jamerson K, Weber MA, Bakris GL et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high risk patients. N. Engl. J. Med.359, 2417–2428 (2008).
   PubMed Web of Science ®Google Scholar
• Fogari R, Zoppi A, Derosa G et al. Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. J. Hum. Hypert.21, 220–224 (2007).
   PubMed Web of Science ®Google Scholar